Arterial fibromuscular dysplasia associated with severe alpha 1-antitrypsin deficiency.
OBJECTIVE
To elucidate the putative arteriopathy associated with alpha 1-antitrypsin (alpha 1-AT) deficiency.


METHODS
We retrospectively studied the frequency of occurrence of fibromuscular dysplasia (FMD) in patients with alpha 1-AT deficiency in whom a postmortem examination had been done during a 10-year period at the Mayo Clinic.


METHODS
The medical records of all patients in whom an autopsy was done at the Mayo Clinic between 1983 and 1992 were reviewed to identify all those with a diagnosis of alpha 1-AT deficiency or FMD.


RESULTS
Arterial FMD was found in 2 of 6 patients with alpha 1-AT deficiency (33.3%; 95% confidence interval, 4.3 to 77.7%) in comparison with 23 of 6,690 patients without alpha 1-AT deficiency (0.3%; 95% confidence interval, 0.2 to 0.5%). In both patients with alpha 1-AT deficiency and FMD, the arterial media was thickened and composed of irregular arrays of muscular and connective tissue fibers in a background of mucoid ground substance.


CONCLUSIONS
These findings provide further evidence for an underlying arteriopathy in patients with alpha 1-AT deficiency and suggest that FMD may be a non-specific disorder.
Department of Neurologic Surgery, Mayo Clinic Rochester, MN 55905.
W I
WI
Schievink
J
J
Björnsson
J E
JE
Parisi
U B
UB
Prakash
D000328:Adult; D000368:Aged; D005260:Female; D005352:Fibromuscular Dysplasia / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007083:Iliac Artery / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012077:Renal Artery / Q000473:pathology; D012189:Retrospective Studies; D019896:alpha 1-Antitrypsin Deficiency